Immune checkpoint inhibitors in the treatment of glioblastoma multiforme

dc.contributor.author	Winnicka, Adrianna
dc.date.accessioned	2024-09-24T10:27:56Z
dc.date.available	2024-09-24T10:27:56Z
dc.date.issued	2024-09-18
dc.identifier.issn	1730-2366
dc.identifier.uri	http://hdl.handle.net/11089/53220
dc.language.iso	en
dc.publisher	Wydawnictwo Uniwersytetu Łódzkiego	pl
dc.relation.ispartofseries	Acta Universitatis Lodziensis. Folia Biologica et Oecologica	en
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.subject	glioblastoma multiforme	en
dc.subject	immunotherapy	en
dc.subject	immune checkpoint inhibitors	en
dc.subject	monoclonal antibodies	en
dc.subject	neurooncology	en
dc.title	Immune checkpoint inhibitors in the treatment of glioblastoma multiforme	en
dc.type	Article
dc.page.number	13-13
dc.contributor.authorAffiliation	University of Lodz, Faculty of Biology and Environmental Protection, Poland	en
dc.identifier.eissn	2083-8484
dc.references	Yasinjan, F., Xing, Y., Geng, H., Guo, R., Yang, L., Liu, Z., Wang, H. 2023. Immunotherapy: a promising approach for glioma treatment. Frontiers in Immunology, 14, 1255611.	en
dc.references	Linares, C.A., Varghese, A., Ghose, A., Shide, S.D., Adeleke, S., Sanchez, E., Sheriff, M., Chargari, C., Rassy, E., Boussios, S. 2023. Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities. International Journal of Molecular Sciences, 24(17), 13215.	en
dc.contributor.authorEmail	adrianna.winnicka@edu.uni.lodz.pl
dc.identifier.doi	10.18778/1730-2366.18.05
dc.relation.volume	18

Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0